One common complaint I hear from biotech entrepreneurs is that negotiating a license agreement with a university can be a nightmare. There are universities—some of them within the very top echelons of academia—that are infamous for having technology transfer people who are described as very difficult to work with. It’s not that surprising that these … Continue reading “A One-Size-Fits-All License Agreement: The Holy Grail of Tech Transfer?”
Category: National
Google Sued by Skyhook, Big Funding Rounds for Crowdsourcers Get Satisfaction and uTest, & More Bay Area BizTech News
And I thought August was busy. As September entered its third week (where did the summer go, exactly?), the news on acquisitions, fundings, product launches, and lawsuits accelerated to a manic pace. —Google was on the receiving end of a pair of lawsuits filed by Boston-based Skyhook Wireless on Wednesday. A pioneer in location-finding software … Continue reading “Google Sued by Skyhook, Big Funding Rounds for Crowdsourcers Get Satisfaction and uTest, & More Bay Area BizTech News”
L-1 Acquired by Safran and BAE in $1.6B Merger Deal
L-1 Identity Solutions, a Stamford, CT-based maker of biometric technologies for security and identification, said today it has agreed to be acquired by French aerospace and defense company Safran for $12 per share in a merger transaction. As part of the deal, L-1 is first selling off a chunk of its business to U.K.-based BAE … Continue reading “L-1 Acquired by Safran and BAE in $1.6B Merger Deal”
Boston Scientific to Inhale Asthmatx in $194M Buyout
Boston Scientific (NYSE:[[ticker:BSX]]) is upping its investment in a new way of treating severe asthma. The Natick, MA-based medical device giant says today it has inked a deal to acquire Sunnyvale, CA-based Asthmatx for $193.5 million. Boston Scientific, which had previously been an investor in Asthmatx, has presumably been following the California firm’s progress for … Continue reading “Boston Scientific to Inhale Asthmatx in $194M Buyout”
Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase
Lee Hartwell would be excused if he wanted to rest on his laurels at the age of 70 and enjoy the sort of retirement that you read about in personal finance magazines. Instead, he’s now setting out to do the most ambitious things of his career. He wants to change the way the world thinks … Continue reading “Lee Hartwell, at 70, Tackles Personalized Medicine, Education in Latest Career Phase”
Do You Know Where Your Child (or Husband or Girlfriend) Is? Whereoscope Can Tell You
This is the eighth in a series of profiles of companies funded this summer by Paul Graham’s Mountain View, CA-based startup incubator, Y Combinator. Every day millions of people check in or submit geotagged updates using mobile-friendly services like Foursquare, Gowalla, Twitter, SCVNGR, Google Latitude, and Facebook Places, sharing their locations with the whole social-networking … Continue reading “Do You Know Where Your Child (or Husband or Girlfriend) Is? Whereoscope Can Tell You”
Netezza Sold to IBM for $1.7B, Will Help Big Blue Tackle Big Data
The hits keep coming for IBM in Massachusetts—and this one is a biggie. The company (NYSE: [[ticker:IBM]]) announced this morning it plans to acquire Marlborough, MA-based Netezza (NYSE: [[ticker:NZ]]), the business analytics and data warehousing firm, for about $1.7 billion in cash. It will be Big Blue’s 18th acquisition of a company based in the … Continue reading “Netezza Sold to IBM for $1.7B, Will Help Big Blue Tackle Big Data”
Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010
Take a fast-food loving culture, mix in a sedentary lifestyle, and, not surprisingly, you get a lot of heart disease in the U.S. The trend doesn’t appear to be changing anytime soon, as the Baby Boomers get older, and an estimated 18 million U.S. adults are living with some form of cardiovascular disease. So if … Continue reading “Four Big Cardiovascular Trends to Watch at this Week’s Medical Device Gathering—TCT 2010”
SG Biofuels Gets $9.4M to Develop Jatropha, Motorola Spinout Could Land in San Diego, Startup Grid2Home Emerges Here, & More San Diego BizTech News
If Motorola’s mobile devices spinout establishes its new headquarters in San Diego, as many as 200 new jobs would be created here. That would be good news, of course, for a county where the unemployment rate in August was just reported to be 10.6 percent. We have that and the rest of the BizTech news … Continue reading “SG Biofuels Gets $9.4M to Develop Jatropha, Motorola Spinout Could Land in San Diego, Startup Grid2Home Emerges Here, & More San Diego BizTech News”
The Future of Humankind Depends on Quality Science Education
Each decade produces new insights into science, especially life sciences, where we are learning more about ourselves. As our society becomes increasingly dependent on its scientific legacy, it becomes more and more important that each new generation understands the role of science in our lives. However, the accumulation of facts can be daunting to students … Continue reading “The Future of Humankind Depends on Quality Science Education”
Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior
Mark Corrigan, the chief executive of the biotech Zalicus (NASDAQ:[[ticker:ZLCS]]), has been shuttling back and fourth from Boston to New York this week as part of the Cambridge, MA-based firm’s effort to gain greater visibility on Wall Street. In fact, last Friday he was due to ring the closing bell at the NASDAQ stock market … Continue reading “Zalicus, Formerly the Bicoastal Biotech CombinatoRx, Seeks New Identity with Name Fit for a Warrior”
Kabongo Takes School-Based Learning Games to the Consumer, Focuses on Being Both Fun and Effective
Kids usually don’t do schoolwork at home purely for fun. But Terry Anderson, president and CEO of educational gaming company Kabongo, thinks that his company’s products could provide an exception to that rule. The startup—headquartered in Emeryville, CA, with research operations in Ann Arbor, MI—first marketed its learning-skills-building games directly to schools. But earlier this … Continue reading “Kabongo Takes School-Based Learning Games to the Consumer, Focuses on Being Both Fun and Effective”
IBM’s Software Acquisition Strategy in Massachusetts (Plus Tips on Getting Acquired) From VP Mike Loria
If you looked at a map of IBM’s local operations and software acquisitions—17 in Massachusetts since 2003, out of a total of 60 worldwide—you might think the company’s headquarters was in Massachusetts, not New York. Between its recently opened Mass Lab in Littleton and Westford, MA (the firm’s biggest software development lab in North America), … Continue reading “IBM’s Software Acquisition Strategy in Massachusetts (Plus Tips on Getting Acquired) From VP Mike Loria”
Motorola Mobility CEO Sanjay Jha Talks Cloud Computing Strategy—and Eyes Bringing Mobile Division to San Diego
Sanjay Jha was lured from Qualcomm (NASDAQ: [[ticker:QCOM]]) to serve as co-CEO of Schaumburg, IL-based Motorola (NYSE: [[ticker:MOT]]) and the CEO of the nearby Motorola Mobility division, which includes mobile handsets, wireless accessories, and home digital media devices. Now there’s a chance the wireless industry’s prodigious son might return to San Diego—and bring the headquarters … Continue reading “Motorola Mobility CEO Sanjay Jha Talks Cloud Computing Strategy—and Eyes Bringing Mobile Division to San Diego”
Can #NewTwitter Swim Faster Than a Fail Whale?
The Coast Guard reported Thursday that a ship entering San Francisco Bay struck a 25-foot whale and dragged it all the way to Berth 57 at the Port of Oakland, where it was pronounced DOA. (I’m not joking.) If you worked at San Francisco-based Twitter and you were looking for bad omens, this might be … Continue reading “Can #NewTwitter Swim Faster Than a Fail Whale?”
Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence
The CEO of Lycera, one of Michigan’s high-profile biotech startups, has left the company after less than a year on the job. CEO Bill Sibold, the former Biogen Idec executive who was hired to lead the Plymouth, MI-based startup in January, has resigned to pursue other interests, Xconomy has confirmed. Sibold’s corporate biography no longer … Continue reading “Lycera CEO Resigns After Less Than One Year, Michigan Startup Plans to Keep Boston Presence”
Nodality’s Personalized Medicine Recipe, Relypsa Pockets $70M, Big Oil Likes Seaweed Biofuel, & More Bay Area Life Sciences News
One of the best things about covering life sciences innovation is weeks like this when we get to write about topics as diverse as seaweed biofuel and personalized cancer treatment. Get caught up on the week’s biotech headlines here. —One fascinating new take on personalized cancer treatment is emerging in South San Francisco at Nodality, … Continue reading “Nodality’s Personalized Medicine Recipe, Relypsa Pockets $70M, Big Oil Likes Seaweed Biofuel, & More Bay Area Life Sciences News”
Intel and the Three Ds of the App Store Business
Where are app stores going next? For the past few years, the app store model has spread through the wireless ecosystem like wildfire. There have been a few big winners and lots of…well, losers is probably too strong, but let’s say there are a lot of app stores that have yet to reach critical mass. … Continue reading “Intel and the Three Ds of the App Store Business”
Smartsheet Raises $1.5M From Madrona, Riding Wave of Support from Google Apps Marketplace
Smartsheet, the Bellevue, WA-based collaborative project management software company, has raised $1.5 million more in a Series C round led by existing investor Madrona Venture Group. The company, founded in 2005 by local entrepreneur Brent Frei, develops business software that helps companies oversee online project management, manage team-based collaboration, file share, and track outsourced tasks. … Continue reading “Smartsheet Raises $1.5M From Madrona, Riding Wave of Support from Google Apps Marketplace”
Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News
All eyes continued to be on Genzyme this week, but other New England life sciences companies had interesting developments to report as well. —Good Start Genetics, a three-year-old Boston startup built in part around technology from the Harvard lab of George Church, completed an $18 million Series A round of funding from OrbiMed Advisors, Safeguard … Continue reading “Ironwood Drug Passes Clinical Test, Genzyme Cuts Jobs and Sheds Business Unit, Third Rock Closes $426M Fund, & More Boston-Area Life Sciences News”
We Can Get There From Here: The Automotive X Prize Awards $10 Million to 3 Winners
A very light car powered by an internal combustion engine (and fueled by a standard gasoline-ethanol blend known as E85) won the $5 million purse today in the Progressive Automotive X Prize—proving you don’t need an electric vehicle to get over 100 mpg. The nonprofit X Prize Foundation and Progressive Insurance, which sponsored the automotive … Continue reading “We Can Get There From Here: The Automotive X Prize Awards $10 Million to 3 Winners”
Cell Therapeutics Finds Way to Survive, Persuading Investors to OK Sale of 400M Shares
[Updated: 6:20 pm Pacific] Cell Therapeutics isn’t ready to close its doors just yet, even after suffering what could have been a fatal setback this year. The Seattle-based biotech company (NASDAQ: [[ticker:CTIC]]), which had a new drug application soundly rejected by the FDA in April, said today that shareholders have given it the green light … Continue reading “Cell Therapeutics Finds Way to Survive, Persuading Investors to OK Sale of 400M Shares”
Arena Pharmaceuticals Obesity Drug Shot Down by FDA Panel
San Diego-based Arena Pharmaceuticals (NASDAQ: [[ticker:ARNA]]) and its partner, Japan-based Eisai Pharmaceuticals, suffered a big-time setback today in their quest to bring a new obesity drug to the U.S. market. The FDA’s expert advisory panel on endocrinology and metabolic drugs said today in a 9-5 vote that lorcaserin (Lorqess) shouldn’t be approved for sale in … Continue reading “Arena Pharmaceuticals Obesity Drug Shot Down by FDA Panel”
What We Can Learn from the Flight of Microsoft Execs to Amazon, AOL, GM, Nokia, Yahoo…and Micro VC
Sometimes all you need to do is look at where former Microsoft executives are going, to piece together some interesting trends in the tech industry. In recent months, a number of high-profile leaders from very different divisions of the Redmond, WA-based software firm (NASDAQ: [[ticker:MSFT]]) have departed. This might be true in any given year … Continue reading “What We Can Learn from the Flight of Microsoft Execs to Amazon, AOL, GM, Nokia, Yahoo…and Micro VC”
Six Angel Investors Share Lessons of Wins & Losses at Zino Society Investment Forum
Every year the Zino Society‘s Zillionaire Investment Forum is a must-go event for entrepreneurs looking for funding opportunities and investors looking for new projects. The one-day forum is a chance for startups and young companies to pitch five minute presentations, rub shoulders with potential investors, demo products, sit in on panels with local venture capitalists … Continue reading “Six Angel Investors Share Lessons of Wins & Losses at Zino Society Investment Forum”
Entrepreneurial Walk of Fame Gets Some Legs at Cambridge City Hall Meeting
What happens when entrepreneurship meets politics? A task force forms and an idea inches its way forward. The idea I’m talking about is an Entrepreneurial Walk of Fame, akin to Hollywood’s celebration of movie stars, in Cambridge’s own Kendall Square, a proposal that Xconomy’s CEO Bob Buderi first wrote about last month. MIT Entrepreneurship Center … Continue reading “Entrepreneurial Walk of Fame Gets Some Legs at Cambridge City Hall Meeting”
Lorcaserin Weight-Loss Trials Weigh Heavily on Arena, Ramius Raises Offer to Buy Cypress Bio, Santarus Adds to Its Drug Portfolio, & More San Diego Life Sciences News
The game is afoot for Ramius Value and Opportunity Advisors, the private equity group in New York pursuing San Diego’s Cypress Bioscience, as it made a direct appeal to Cypress shareholders to support its unsolicited buyout offer. At Xconomy, we’re issuing a direct appeal to get your life sciences news here. —The stage has been … Continue reading “Lorcaserin Weight-Loss Trials Weigh Heavily on Arena, Ramius Raises Offer to Buy Cypress Bio, Santarus Adds to Its Drug Portfolio, & More San Diego Life Sciences News”
Nodality Nears Market With Technology to Get the Right Cancer Drug to the Right Patients
One fascinating new idea in predictive, personalized medicine is starting to gather momentum in South San Francisco. Nodality, a Stanford University spinoff from the lab of biologist Garry Nolan, is now on the cusp of going commercial with technology to help Big Pharma companies, and doctors, better understand why individuals respond differently to drugs, and … Continue reading “Nodality Nears Market With Technology to Get the Right Cancer Drug to the Right Patients”
NanoBio Passes First Key Clinical Trial With Nasal Flu Vaccine, Scopes Other Opportunities
NanoBio has its sights set on developing a new generation of vaccines against the flu and other pathogens, and this past week the Ann Arbor, MI-based company showed the first real evidence in human beings that its approach might work. An initial study of 199 healthy adults, presented over the weekend at the Interscience Conference … Continue reading “NanoBio Passes First Key Clinical Trial With Nasal Flu Vaccine, Scopes Other Opportunities”
A Closer Look at IBM’s Recent Massachusetts Acquisitions—Some Trends and Analysis
Yesterday, IBM announced it is acquiring Waltham, MA-based OpenPages, a corporate governance, risk, and compliance software company. That’s an interesting story in itself, but it’s also part of a prominent business trend that has major impact on the New England software and computing ecosystem. OpenPages is IBM’s 17th acquisition of a company based in Massachusetts … Continue reading “A Closer Look at IBM’s Recent Massachusetts Acquisitions—Some Trends and Analysis”
Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences
Seattle biotech is still buzzing more than a week later about Bristol-Myers Squibb’s acquisition of ZymoGenetics (NASDAQ: [[ticker:ZGEN]]) and whether it means we live in some dead-end biotech loserville. If you have some thoughts on this, please shoot me a note, because the last words haven’t yet been written on the Zymo deal. —Everyone wants … Continue reading “Seattle Genetics’ Dark Horse Fails, The Future of Zymo’s Landmark, PATH Nabs Flu Vaccine Contract, & More Seattle-Area Life Sciences”
Skyhook, Fighting for Its Life in Suit Against Google, Cries Foul: “Call in the Referees and Review the Tape”
Boston-based Skyhook Wireless, in what could be a fight for its life, is taking a double-barreled legal shot at Google. In a pair of lawsuits filed against the search and advertising giant yesterday, the seven-year-old, 32-employee startup says Google illegally copied its location-finding technology and then leaned on business partners to use Google’s version instead … Continue reading “Skyhook, Fighting for Its Life in Suit Against Google, Cries Foul: “Call in the Referees and Review the Tape””
Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond
I’ve never actually met the folks at FierceBiotech in person, but today I felt like we had undergone some kind of Vulcan mind meld. The online industry publication unveiled its annual Fierce 15 list of the 15 most promising private biotech companies in the U.S. What jumped out at me right away? All but one … Continue reading “Fierce 15 Shines Light on Some of Our Favorite Companies in Boston and Beyond”
Grid2Home Gets Granite Ventures Seed Funding for Smart Grid Software
A new “smart grid” startup has emerged in San Diego. Grid2Home, which describes itself as a “smart energy communications company” that develops software for wired and wireless home area networks (HAN), is joining a technology land-rush among San Diego wireless and software companies seeking to stake a claim in smart grid territory. The local stampede … Continue reading “Grid2Home Gets Granite Ventures Seed Funding for Smart Grid Software”
Seaweed Biofuel Maker, Bio Architecture Lab, Snags Partnership With Norway’s Statoil
A startup with a dream of turning seaweed into renewable biofuels just got some important validation from a big oil company. Berkeley, CA-based Bio Architecture Lab said today it has secured a partnership with the world’s biggest offshore oil and gas producer, Norway-based Statoil, to build up capabilities to turn seaweed from off the Norwegian … Continue reading “Seaweed Biofuel Maker, Bio Architecture Lab, Snags Partnership With Norway’s Statoil”
In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer
[Corrected 9/16/10, 2:00 pm. See below.] San Diego’s Cypress Bioscience (NASDAQ: [[ticker:CYPB]]), which has been stubbornly refusing to negotiate or even meet with a private equity firm over an unsolicited buyout offer, says it will review the fund’s increased offer “consistent with its fiduciary duties.” Ramius Value and Opportunity Advisors, a subsidiary of the $7.8 … Continue reading “In Appeal to Cypress Bio Stockholders, Ramius Raises Buyout Offer”
Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder
Genzyme and Third Rock Ventures bet $35 million six months ago on a Cambridge, MA-based gene therapy company. Despite all the ups and downs with gene therapy over the years, now we can see why they placed the bet. The newly renamed Bluebird Bio, formerly known as Genetix Pharmaceuticals, is coming out today with an … Continue reading “Bluebird Bio, Third Rock & Genzyme’s Gene Therapy Bet, Shows Promise for Blood Disorder”
Qualcomm Renews, Expands QPrize for Early Stage Startups
San Diego-based Qualcomm chose the Demo Fall 2010 conference in Santa Clara yesterday to announce the second round of the Qualcomm Ventures QPrize, an international venture financing competition for early stage startups. The wireless giant’s venture arm inaugurated the QPrize last year, offering a total of $550,000 in “incentive financing” to finalists from China, India, … Continue reading “Qualcomm Renews, Expands QPrize for Early Stage Startups”
IBM Buys OpenPages, 17th Massachusetts Acquisition Since 2003
Waltham, MA-based OpenPages, a maker of business software for managing corporate risk and compliance activities, is being acquired by IBM for an undisclosed sum. Armonk, NY-based IBM announced the news in a press release this morning. Once the acquisition closes, IBM (NYSE: [[ticker:IBM]]) says it will integrate OpenPages into its Business Analytics software portfolio. This … Continue reading “IBM Buys OpenPages, 17th Massachusetts Acquisition Since 2003”
Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference
Tetraphase Pharmaceuticals raised a big $45 million venture round back in June, and now scientists can see more clearly why it’s been able to raise all that dough. The Watertown, MA-based company made a series of 10 different poster presentations over the past few days at the biggest antibiotics meeting of the year, the Interscience … Continue reading “Tetraphase Shows What the $45M Was All About at Big Antibiotics Conference”
The Fridge: Private Mini-Facebooks that Put Social Networking in Context
This is the seventh in a series of profiles of companies funded this summer by Mountain View, CA-based startup incubator Y Combinator. Facebook is so dominant in the social-networking sphere that it’s easy to forget that there is any other model for socializing online. The reigning ethos in Facebook’s one-size-fits-all environment is that everyone should … Continue reading “The Fridge: Private Mini-Facebooks that Put Social Networking in Context”
Livemocha Seeks to Upend Rosetta Stone, Taking Language Learning to New Heights Online
Livemocha is ready to kick some language learning butt—at least according to chief executive Michael Schutzler. The Bellevue, WA-based startup is already the largest online language learning community in the world, with over six million members from over 200 countries actively studying some 38 languages—not bad numbers for a 3-year-old company. But this isn’t enough … Continue reading “Livemocha Seeks to Upend Rosetta Stone, Taking Language Learning to New Heights Online”
U-M’s Ken Nisbet on Bridging the Gap Between Innovation and Economic Recovery in Michigan
With an annual research budget of more than $1 billion, the University of Michigan is a leading hub of new technological inventions and entrepreneurship. It’s serving as a wellspring of new ideas and startups that are helping to lead the economic recovery in the Great Lakes State. Ken Nisbet plays a key role in advancing … Continue reading “U-M’s Ken Nisbet on Bridging the Gap Between Innovation and Economic Recovery in Michigan”
PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions
One of the big ideas PATH is pursuing to make vaccines more useful just got a strong vote of confidence. The Seattle-based global health nonprofit is announcing today it has secured a $5.2 million contract from the U.S. government to develop flu vaccines that can remain effective for years when they are stashed away in … Continue reading “PATH Snaps Up $5M Contract to Make Flu Vaccines For Stockpiling, Hot Conditions”
GM Updates OnStar Brand for the Era of Mobile, Social Media
Since 1997, owners of selected General Motors vehicles have had the option of subscribing to OnStar, a cellular service that lets drivers make hands-free phone calls, hear turn-by-turn navigational cues, receive remote diagnostic reports, and get emergency support in accidents. In the car business, 13 years is a long time—but in the world of mobile … Continue reading “GM Updates OnStar Brand for the Era of Mobile, Social Media”
Notes from the Opening of A123Systems’ Michigan Manufacturing Plant
Under cloudless blue skies in Livonia, MI, many of those at the forefront of electrification of vehicles gathered on Monday to celebrate the opening of A123 Systems’ lithium ion battery manufacturing plant. From political leaders to business executives and scientists, an array of notable speakers highlighted new and important progress on advanced batteries and vehicle … Continue reading “Notes from the Opening of A123Systems’ Michigan Manufacturing Plant”
Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News
New England’s life sciences companies inked the majority of this week’s deals, but several software firms had interesting business to report as well. —Boston-based startup Rhythm Pharmaceuticals completed its Series A financing round with a total of $40 million. Third Rock Ventures participated in the closing, joining MPM Capital and New Enterprise Associates, who led … Continue reading “Genzyme Sheds Testing Unit, Red Bend Acquires VirtualLogix, Acceleron Forges Alliance with Shire, & More Boston-Area Deals News”
RealNetworks Acquires Backstage Technologies, Commits to Making GameHouse Social
Seattle-based digital entertainment services company RealNetworks (NASDAQ: [[ticker:RNWK]]) has acquired Canadian social games company Backstage Technologies for an undisclosed amount. The deal, according to Real, will add valuable game engineering and monetizing expertise to Real’s digital gaming division, GameHouse, as it works on its own expansion into the social gaming marketplace. “As we transform RealNetworks, … Continue reading “RealNetworks Acquires Backstage Technologies, Commits to Making GameHouse Social”
Why We Think Investing in Antibiotics Makes Sense
In 20-plus years treating people with infectious disease, Dr. Gavin McLeod has seen plenty of patients with HIV, transplants or cancer, hospitalized from respiratory distress caused by a secondary infection from a virus or bacteria. Sometimes McLeod or his Stamford (Connecticut) Hospital colleagues could diagnose the problem: perhaps it was cytomegalovirus, a common secondary infection … Continue reading “Why We Think Investing in Antibiotics Makes Sense”
Zillow Promotes Spencer Rascoff to CEO, Rich Barton Stays on as Executive Chairman
Zillow, the Seattle-based real estate website, mobile platform, and mortgage marketplace, said today that it has promoted chief operating officer Spencer Rascoff to CEO. Rascoff, who joined Zillow as part of its original executive team in 2005, is taking the place of co-founder Rich Barton, who has served as chief executive since the company’s founding. … Continue reading “Zillow Promotes Spencer Rascoff to CEO, Rich Barton Stays on as Executive Chairman”